Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials-Reference-Cited by-同舟云学术

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Published:2014-05-05 Issue:3 Volume:59 Page:345-354
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Johnson Stuart¹,Louie Thomas J.²,Gerding Dale N.¹,Cornely Oliver A.³,Chasan-Taber Scott⁴,Fitts David⁵,Gelone Steven P.⁵,Broom Colin⁵,Davidson David M.⁴,

Affiliation:

1. Loyola University Medical Center and Hines Veterans Administration Hospital, Chicago, Illinois

2. University of Calgary, Alberta, Canada

3. Department of Internal Medicine, Clinical Trials Centre Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Germany

4. Genzyme, Cambridge, Massachusetts

5. ViroPharma Incorporated, Exton, Pennsylvania

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/59/3/345/17351994/ciu313.pdf

Reference26 articles.

1. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003;McDonald;Emerg Infect Dis,2006

2. Increase in Clostridium difficile-related mortality rates, United States, 1999–2004;Redelings;Emerg Infect Dis,2007

3. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada;Pepin;Clin Infect Dis,2005